Antifungal use influences Candida species distribution and susceptibility in the intensive care unit | Zendy

PierreEdouard Fournier | Zendy; Carole Schwebel | Zendy; Danièle Maubon | Zendy; Aurélien Vésin | Zendy; B. Lebeau | Zendy; L. Foroni | Zendy; Rébecca Hamidfar-Roy | Zendy; Muriel Cornet | Zendy; JeanFrançois Timsit | Zendy; Hervé Pelloux | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antifungal use influences Candida species distribution and susceptibility in the intensive care unit

Author(s) -

PierreEdouard Fournier,

Carole Schwebel,

Danièle Maubon,

Aurélien Vésin,

B. Lebeau,

L. Foroni,

Rébecca Hamidfar-Roy,

Muriel Cornet,

JeanFrançois Timsit,

Hervé Pelloux

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr394

Subject(s) - caspofungin , fluconazole , candida parapsilosis , candida glabrata , amphotericin b , antifungal drug , corpus albicans , candida albicans , microbiology and biotechnology , biology , medicine , intensive care unit , antifungal

Antifungal prescription practices have changed over the last decade, and the impact of these changes is unclear. Our objective here was to evaluate the effect of antifungal drug use on the distribution and drug susceptibility of Candida spp. in a French intensive care unit (ICU).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research